Published in Prostaglandins on January 10, 1974
Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency. Proc Natl Acad Sci U S A (1975) 1.74
1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. Am J Pathol (1981) 1.56
13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor. Proc Natl Acad Sci U S A (1979) 1.33
Neutrophil aggregation and degranulation. Effect of arachidonic acid. Am J Pathol (1979) 1.15
Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins. Biochem J (1978) 1.14
Phorbol myristate acetate: in vivo effects upon neutrophils, platelets, and lung. Am J Pathol (1980) 1.11
Proceedings: Thrombolytic and anti-thrombotic properties of dihomo-gamma-linolenate in vitro. Br J Pharmacol (1975) 1.11
The influence of aspirin and indomethacin on the platelet contractile wave. Am J Pathol (1976) 1.01
Vitamin E. An inhibitor of the platelet release reaction. J Clin Invest (1976) 0.98
Comparison of the effects of prostaglandin analogues on rabbit platelets, rabbit isolated vascular tissues and rabbit skin microvasculature [proceedings]. Br J Pharmacol (1978) 0.85
Proceedings: Effects of prostaglandins E1, E2 and D2 on platelet aggregation: variation with animal species and ionized calcium concentration. Br J Pharmacol (1975) 0.79
Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion. Am J Pathol (1977) 0.78
Platelets, acute inflammation and inflammatory mediators. Agents Actions (1976) 0.78
Proceedings: Some easy and rapid endoperoxide isolation procedures. Br J Pharmacol (1974) 0.75
Cyclic AMP. Ann Surg (1976) 0.75
Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol (1971) 7.75
Parallel assay of prostaglandin-like activity in rat inflammatory exudate by means of cascade superfusion. J Pharm Pharmacol (1969) 3.59
The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (1974) 3.48
Cutaneous reactions to intradermal prostaglandins. Br J Pharmacol (1971) 2.27
An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin. Science (1974) 2.08
An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance. Prostaglandins (1974) 2.02
Formation and release of prostaglandins by platelets in response to thrombin. Br J Pharmacol (1970) 1.59
Interaction between prostaglandins E and F given intradermally in the rat. Br J Pharmacol (1971) 1.47
Simplified thin-layer chromatography of prostaglanding in biological extracts. Br J Pharmacol (1970) 1.24
A new potential mediator of arterial thrombosis whose biosynthesis is inhibited by aspirin. Prostaglandins (1973) 1.17
A congenital defect in platelet prostaglandin production associated with impaired hemostasis in storage pool disease. Prostaglandins (1973) 1.17
Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo. Prostaglandins (1974) 1.16
Inhibition of intestinal tone and prostaglandin synthesis by 5,8,11,14 tetraynoic acid. Br J Pharmacol (1972) 1.16
Proceedings: Thrombolytic and anti-thrombotic properties of dihomo-gamma-linolenate in vitro. Br J Pharmacol (1975) 1.11
Antithrombotic potential of dihomo-gamma-linolenic acid in man. Br Med J (1977) 1.10
Repeated injection of prostaglandin E2 in rat paws induces chronic swelling and a marked decrease in pain threshold. Prostaglandins (1973) 1.08
Actions and interactions of prostaglandins administered intradermally in rat and in man. Br J Pharmacol (1969) 1.00
Inhibition of intestinal tone, motility and prostaglandin biosynthesis by 5,8,11,14-eicosatetraynoic acid (TYA). Prostaglandins (1974) 0.98
Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits. Arteriosclerosis (1985) 0.95
Nutritional and pharmacological factors in eicosanoid biology. Nutr Rev (1981) 0.89
Trimethoquinol is a potent prostaglandin endoperoxide antagonist [proceedings]. Br J Pharmacol (1978) 0.86
Acetylenic analog of arachidonate that acts like aspirin on platelets. Science (1974) 0.85
Effects of prostaglandins and their precursors in some tests of hemostatic function. Prog Lipid Res (1981) 0.84
Eicosanoid effects on cell proliferation in vitro: relevance to atherosclerosis. Prostaglandins Leukot Med (1984) 0.82
Influence of vitamin E on platelet aggregation and thrombocythemia in the rat. Proc Soc Exp Biol Med (1975) 0.81
Prostaglandin E2 potentiation of platelet aggregation induced by LASS endoperoxide: absent in storage pool disease, normal after aspirin ingestion. Br J Haematol (1976) 0.80
The metabolism of dihomo-gamma-linolenic acid in man. Lipids (1979) 0.79
Inhibition of platelet-derived mitogen release by nitric oxide (EDRF). Agents Actions (1989) 0.79
Proceedings: Prostaglandin E2, inflammation and pain threshold in rat paws. Br J Pharmacol (1973) 0.77
Eskimo plasma constituents, dihomo-gamma-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid inhibit the release of atherogenic mitogens. Lipids (1989) 0.77
Effects of prostacyclin and orally active stable mimetic agent RS-93427-007 on basic mechanisms of atherogenesis. Lancet (1986) 0.77
Prostaglandins and the future of medicine (an overview of currently evolving data and ideas). 1. Introductory comments: outline and scope of the series. Prostaglandins (1974) 0.76
A suggested shorthand nomenclature for the eicosanoids. Lipids (1987) 0.76
On the identification and biological properties of prostaglandin J2. Prostaglandins Leukot Med (1984) 0.75
Proceedings: Some easy and rapid endoperoxide isolation procedures. Br J Pharmacol (1974) 0.75
A convenient method for isolation and bioassay of prostaglandins E1, E2, F2 and D2 [proceedings]. Br J Pharmacol (1978) 0.75
Levels of prostaglandins and their precursors in EFA-deficient rabbits--a new concept of prostaglandin biosynthesis [proceedings]. Br J Pharmacol (1978) 0.75
A method for studying release of prostaglandins from superfused strips of isolated spleen. Br J Pharmacol (1970) 0.75
Mechanisms responsible for inhibition of vein-graft arteriosclerosis by fish oil. Circulation (1989) 0.75
Detection of prostaglandin induction of erythrocyte sickling. Clin Chem (1973) 0.75
Dihomo-gamma-linolenic acid as the endogenous protective agent for myocardial infarction. Lancet (1984) 0.75
Relationships between prostaglandins, prostacyclin and EFA precursors in rabbits maintained on EFA-deficient diets. Prog Lipid Res (1981) 0.75
Some perspectives on platelets and prostaglandins. Prog Lipid Res (1981) 0.75
Simplified extraction, chromatography and bioassay of prostaglandins in biological extracts (T). Br J Pharmacol (1972) 0.75
Prostaglandin F 2 may induce sickle-cell crisis. N Engl J Med (1972) 0.75
Platelet aggregation inhibitory activity and vasodepressor activity of a series of bicyclo[3.2.0]hept-6-ylidene iminoxy alkanoic acids with modified lower side chains. Prostaglandins (1987) 0.75
Unanswered questions in EFA and PG research. Prog Lipid Res (1981) 0.75